Mackenzie Financial Corp increased its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 157.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 111,479 shares of the company's stock after buying an additional 68,121 shares during the quarter. Mackenzie Financial Corp's holdings in Avantor were worth $1,807,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Dodge & Cox boosted its stake in shares of Avantor by 44.9% during the fourth quarter. Dodge & Cox now owns 99,145,770 shares of the company's stock valued at $2,089,001,000 after purchasing an additional 30,727,673 shares during the period. The Manufacturers Life Insurance Company raised its position in Avantor by 48.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 9,158,175 shares of the company's stock valued at $192,963,000 after purchasing an additional 2,983,439 shares during the period. Clarkston Capital Partners LLC lifted its holdings in Avantor by 43.6% during the 4th quarter. Clarkston Capital Partners LLC now owns 8,145,825 shares of the company's stock valued at $171,633,000 after buying an additional 2,473,395 shares in the last quarter. FMR LLC boosted its position in Avantor by 49.6% during the fourth quarter. FMR LLC now owns 6,992,096 shares of the company's stock valued at $147,323,000 after purchasing an additional 2,316,813 shares in the last quarter. Finally, Van Lanschot Kempen Investment Management N.V. grew its stake in Avantor by 62.2% during the 4th quarter. Van Lanschot Kempen Investment Management N.V. now owns 4,699,584 shares of the company's stock valued at $99,020,000 after purchasing an additional 1,801,483 shares during the last quarter. Institutional investors own 95.08% of the company's stock.
Insider Buying and Selling at Avantor
In other news, Director Gregory L. Summe purchased 30,000 shares of the company's stock in a transaction dated Friday, May 23rd. The shares were acquired at an average cost of $12.50 per share, for a total transaction of $375,000.00. Following the completion of the purchase, the director directly owned 100,000 shares in the company, valued at $1,250,000. The trade was a 42.86% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Steven W. Eck sold 3,476 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total value of $39,591.64. Following the sale, the chief accounting officer owned 55,068 shares in the company, valued at approximately $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.
Avantor Stock Up 1.3%
Shares of NYSE AVTR traded up $0.15 during trading hours on Thursday, hitting $11.33. The company had a trading volume of 8,309,384 shares, compared to its average volume of 10,653,608. The firm's 50 day moving average is $13.28 and its 200-day moving average is $15.27. Avantor, Inc. has a 1-year low of $10.82 and a 1-year high of $27.83. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $7.72 billion, a P/E ratio of 11.45, a price-to-earnings-growth ratio of 1.31 and a beta of 0.96.
Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a return on equity of 11.39% and a net margin of 10.31%. The company had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. During the same quarter in the previous year, the business earned $0.25 EPS. The company's revenue for the quarter was down 1.1% on a year-over-year basis. On average, analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on AVTR. JPMorgan Chase & Co. reduced their price target on shares of Avantor from $17.00 to $14.00 and set an "overweight" rating for the company in a report on Monday. Morgan Stanley dropped their price target on Avantor from $15.00 to $12.00 and set an "equal weight" rating on the stock in a research note on Monday. Cowen downgraded shares of Avantor from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Wells Fargo & Company decreased their target price on shares of Avantor from $19.00 to $16.00 and set an "overweight" rating on the stock in a report on Monday. Finally, Robert W. Baird lowered their price objective on shares of Avantor from $18.00 to $15.00 and set an "outperform" rating for the company in a report on Monday. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, Avantor currently has a consensus rating of "Hold" and a consensus target price of $15.50.
View Our Latest Analysis on AVTR
Avantor Profile
(
Free Report)
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading

Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report